BioSpace News Archive

Drug Development

Innocoll, Inc. Announces Dosing of First Patient in a Third US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain

July 28, 2008
·
4 min read
Drug Development

First Half 2008 Financial Results: NicOx SA Nears Completion of Phase 3 Naproxcinod Studies

July 28, 2008
·
1 min read
Biotech Bay

Terarecon, Inc. Unveils 3D Image Management, Collaboration and Distribution Enhancements at AHRA 2008

July 28, 2008
·
1 min read
Business

Infinity Pharmaceuticals, Inc. Announces Conference Call Discussing R&D Progress and Second Quarter 2008 Results

July 28, 2008
·
1 min read
Business

Cytomedix Inc. Retains Dr. David F. Counts, Inventor of Company’s Anti-Inflammatory Peptide Patent

July 28, 2008
·
1 min read
Business

Hana Biosciences, Inc. Announces Conference Call On Second Quarter Financial Results and Business Update

July 28, 2008
·
1 min read
Lone Star Bio

Xoft Inc. Electronic Brachytherapy Accurately Delivers Non-Radioactive Therapy Directly to Breast and Endocavitary Cancer Sites

July 28, 2008
·
4 min read
Business

OXiGENE Announces Second Quarter 2008 Earnings Conference Call and Webcast

July 28, 2008
·
1 min read
Pharm Country

GlaxoSmithKline Head-to-head Study Results Demonstrated No Significant Difference Between NicoDerm(R) CQ(R) and Chantix (Varenicline Tartrate) in Long Term Quit Rates

July 28, 2008
·
5 min read
Biotech Bay

Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of ‘Start Clean’ Strategy

July 28, 2008
·
5 min read